429 related articles for article (PubMed ID: 20819899)
1. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
Watterberg KL;
Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
[TBL] [Abstract][Full Text] [Related]
2. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
[TBL] [Abstract][Full Text] [Related]
3. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
Jobe AH
N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647
[No Abstract] [Full Text] [Related]
4. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?
Thébaud B; Lacaze-Masmonteil T; Watterberg K
Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479
[No Abstract] [Full Text] [Related]
5. Evidence-based neonatal pharmacotherapy: postnatal corticosteroids.
Watterberg K
Clin Perinatol; 2012 Mar; 39(1):47-59. PubMed ID: 22341536
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
Dani C; Bertini G; Simone P; Rubaltelli FF
Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
[No Abstract] [Full Text] [Related]
7. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
8. Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.
Onland W; van Kaam AH; De Jaegere AP; Offringa M
Pediatrics; 2010 Oct; 126(4):e954-64. PubMed ID: 20837588
[TBL] [Abstract][Full Text] [Related]
9. Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.
Jensen EA; Watterberg KL
Neoreviews; 2023 Nov; 24(11):e691-e703. PubMed ID: 37907402
[TBL] [Abstract][Full Text] [Related]
10. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
[TBL] [Abstract][Full Text] [Related]
11. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
Yates HL; Newell SJ
Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F190-4. PubMed ID: 21115554
[TBL] [Abstract][Full Text] [Related]
12. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
Yeh TF; Lin YJ; Lin HC; Huang CC; Hsieh WS; Lin CH; Tsai CH
N Engl J Med; 2004 Mar; 350(13):1304-13. PubMed ID: 15044641
[TBL] [Abstract][Full Text] [Related]
13. Progress needed in bronchopulmonary dysplasia.
Mushtaq A
Lancet Respir Med; 2019 Apr; 7(4):300-301. PubMed ID: 30833220
[No Abstract] [Full Text] [Related]
14. Corticosteroids for the treatment and prevention of bronchopulmonary dysplasia.
Soll RF
Neonatology; 2010; 98(2):109-10. PubMed ID: 20150749
[No Abstract] [Full Text] [Related]
15. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
Forest S
J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
[TBL] [Abstract][Full Text] [Related]
16. Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
Eichenwald EC; Stark AR
Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F334-7. PubMed ID: 17712183
[TBL] [Abstract][Full Text] [Related]
17. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
Doyle LW; Cheong JLY
Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126
[TBL] [Abstract][Full Text] [Related]
19. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents.
ter Wolbeek M; de Sonneville LM; de Vries WB; Kavelaars A; Veen S; Kornelisse RF; van Weissenbruch M; Baerts W; Liem KD; van Bel F; Heijnen CJ
Psychoneuroendocrinology; 2013 Jul; 38(7):975-86. PubMed ID: 23107421
[TBL] [Abstract][Full Text] [Related]
20. Steroid therapy and the treatment of bronchopulmonary dysplasia: an error in neonatology, or an unavoidable therapeutic intervention?
Kaplan M
J Perinatol; 2004 Feb; 24(2):127-8; author reply 128-9. PubMed ID: 14872210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
